Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Healthcare ETF Vanguard (VHT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family Vanguard Group
  • Assets Under Management 6,122,723,200
  • Shares Outstanding, K 44,118

Price Performance

See More
Period Period Low Period High Performance
1-Month
137.70 +1.26%
on 04/24/17
141.06 -1.15%
on 05/05/17
+2.93 (+2.15%)
since 04/21/17
3-Month
135.40 +2.98%
on 04/18/17
141.68 -1.58%
on 03/15/17
+2.88 (+2.11%)
since 02/22/17
52-Week
120.38 +15.83%
on 11/03/16
141.68 -1.58%
on 03/15/17
+12.65 (+9.98%)
since 05/20/16

Most Recent Stories

More News
How to Trade "Sell in May and Go Away" With ETFs

The stock market has a long history of weak performance during the summer months (May to October).

USMV : 48.55 (+0.64%)
SPLV : 44.19 (+0.80%)
FDLO : 27.47 (+0.59%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
DEF : 42.08 (+0.62%)
ACWI : 65.51 (+0.40%)
PSQ : 40.19 (-0.81%)
VDC : 142.90 (+0.63%)
SH : 33.96 (-0.53%)
IYH : 157.50 (+0.26%)
IYK : 119.94 (+0.73%)
XLP : 55.66 (+0.56%)
SPY : 239.52 (+0.51%)
DOG : 17.85 (-0.39%)
How to Trade "Sell in May and Go Away" With ETFs

The stock market has a long history of weak performance during the summer months (May to October).

USMV : 48.55 (+0.64%)
SPLV : 44.19 (+0.80%)
FDLO : 27.47 (+0.59%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
DEF : 42.08 (+0.62%)
ACWI : 65.51 (+0.40%)
PSQ : 40.19 (-0.81%)
VDC : 142.90 (+0.63%)
SH : 33.96 (-0.53%)
IYH : 157.50 (+0.26%)
IYK : 119.94 (+0.73%)
XLP : 55.66 (+0.56%)
SPY : 239.52 (+0.51%)
DOG : 17.85 (-0.39%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 139.44 (+0.27%)
JNJ : 127.26 (+0.20%)
MRK : 64.04 (+0.41%)
IYH : 157.50 (+0.26%)
FHLC : 36.22 (+0.28%)
ABBV : 65.44 (-0.21%)
AMG : 153.98 (+0.84%)
GILD : 64.36 (+0.20%)
SPY : 239.52 (+0.51%)
AMGN : 153.02 (-2.23%)
PFE : 32.12 (-1.05%)
BMY : 54.10 (+0.15%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 139.44 (+0.27%)
JNJ : 127.26 (+0.20%)
MRK : 64.04 (+0.41%)
IYH : 157.50 (+0.26%)
FHLC : 36.22 (+0.28%)
ABBV : 65.44 (-0.21%)
AMG : 153.98 (+0.84%)
GILD : 64.36 (+0.20%)
SPY : 239.52 (+0.51%)
AMGN : 153.02 (-2.23%)
PFE : 32.12 (-1.05%)
BMY : 54.10 (+0.15%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
JNJ : 127.26 (+0.20%)
IHE : 148.58 (-0.01%)
IYH : 157.50 (+0.26%)
FHLC : 36.22 (+0.28%)
PFE : 32.12 (-1.05%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
JNJ : 127.26 (+0.20%)
IHE : 148.58 (-0.01%)
IYH : 157.50 (+0.26%)
FHLC : 36.22 (+0.28%)
PFE : 32.12 (-1.05%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 115.71 (-1.04%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
MDCO : 41.06 (-3.52%)
IBB : 291.32 (+0.30%)
PFE : 32.12 (-1.05%)
ESPR : 33.76 (+1.35%)
BBP : 36.47 (-0.73%)
XPH : 41.09 (-0.22%)
ABT : 43.73 (+1.32%)
TMO : 172.10 (+0.33%)
PJP : 58.65 (-0.07%)
IYH : 157.50 (+0.26%)
AMG : 153.98 (+0.84%)
BIIB : 250.04 (-0.02%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 115.71 (-1.04%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
MDCO : 41.06 (-3.52%)
IBB : 291.32 (+0.30%)
PFE : 32.12 (-1.05%)
ESPR : 33.76 (+1.35%)
BBP : 36.47 (-0.73%)
XPH : 41.09 (-0.22%)
ABT : 43.73 (+1.32%)
TMO : 172.10 (+0.33%)
PJP : 58.65 (-0.07%)
IYH : 157.50 (+0.26%)
AMG : 153.98 (+0.84%)
BIIB : 250.04 (-0.02%)
Healthcare ETFs in Focus on Obamacare Replacement Plan

House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.

XHS : 60.23 (+0.05%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
IHF : 139.77 (+0.27%)
IHE : 148.58 (-0.01%)
IBB : 291.32 (+0.30%)
PPH : 56.94 (+0.19%)
BBH : 118.18 (+0.16%)
XPH : 41.09 (-0.22%)
PJP : 58.65 (-0.07%)
FXH : 63.89 (+0.60%)
IYH : 157.50 (+0.26%)
FBT : 107.19 (+0.61%)
XBI : 69.61 (+0.68%)
Healthcare ETFs in Focus on Obamacare Replacement Plan

House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.

XHS : 60.23 (+0.05%)
XLV : 75.23 (+0.27%)
VHT : 139.44 (+0.27%)
IHF : 139.77 (+0.27%)
IHE : 148.58 (-0.01%)
IBB : 291.32 (+0.30%)
PPH : 56.94 (+0.19%)
BBH : 118.18 (+0.16%)
XPH : 41.09 (-0.22%)
PJP : 58.65 (-0.07%)
FXH : 63.89 (+0.60%)
IYH : 157.50 (+0.26%)
FBT : 107.19 (+0.61%)
XBI : 69.61 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

Vanguard Health Care ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the MSCI US Investable Market Health Care Index. The Fund invests all of its assets in the stocks that make up the Index, holding each stock in the same proportion as its weighting...

See More

Top 10 Holdings

Support & Resistance

2nd Resistance Point 139.99
1st Resistance Point 139.71
Last Price 139.44
1st Support Level 139.08
2nd Support Level 138.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.